Brandon Capital
Overview
Brandon Capital is a life sciences venture capital firm that invests in early-stage and emerging biomedical technologies in Australasia, the UK, and the US.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vaxxas | Aug 2025 | Series D | Co-investor |
| Entact Bio | Dec 2022 | Series A | Co-investor |
| RAGE Biotech | Sep 2024 | Grant | Co-investor |
| NRG Therapeutics | Sep 2025 | Series B | Co-investor |
| AstronauTx | Oct 2023 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Katharine Giles
Venture Partner
Roberto Solari
Venture Partner
Trent Munro
Venture Partner and Head of Biocatalyst for Queensland
Chris Smith
Partner
Jonathan Tobin
Partner
Melissa McBurnie
Partner & Head of Impact, Investment Manager
Robert Sicilia
Head of Investor Relations
Alex Delbridge
Principal Investment Team
Bob Soh
Senior Investment Manager
Duncan Mackintosh
Senior Investment Manager, Investment Manager
Jess Smith
Investment Manager
Katherine Jackman
Investment Manager
Mara Macdonald
Investment Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Brandon Capital based?
Brandon Capital is headquartered in Melbourne, Australia.
When was Brandon Capital founded?
Brandon Capital was founded in 2007.
How many portfolio companies does Brandon Capital have?
Brandon Capital has 26 portfolio companies in Caplight's dataset.
What are some companies in Brandon Capital's portfolio?
Portfolio companies visible on Caplight include Vaxxas, Entact Bio, RAGE Biotech, NRG Therapeutics, AstronauTx.
What was Brandon Capital's most recent investment shown here?
Brandon Capital's most recent investment in this portfolio sample was in NRG Therapeutics in 2025.
What sectors does Brandon Capital focus on?
Brandon Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Brandon Capital focus on?
Brandon Capital typically invests at the MultiStage stage.
What is Brandon Capital's AUM?
Brandon Capital's assets under management are estimated between $1.0B and $10.0B.